TOKYO, Jan 19, 2023 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. announced today that fully-fledged operations and business activities have begun at Eisai Israel Ltd., a pharmaceutical sales subsidiary recently established in Tel Aviv in the State of Israel (Israel). Eisai Israel is a wholly-owned subsidiary of Eisai’s […]
pharmaceutical
TOKYO, Jan 19, 2023 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. announced that it has been listed in the 2023 Global 100 Most Sustainable Corporations in the World (Global 100), a global ranking by Canada-based media and investment advisory company, Corporate Knights, Inc. This marks Eisai’s seventh inclusion […]
HONG KONG, Nov 14, 2022 – (ACN Newswire via SEAPRWire.com) – China Resources Pharmaceutical Group Limited (“CR Pharmaceutical” or the “Group”) (stock code: 3320) has announced that the Group will once again be included as a constituent stock of the MSCI China Index, which will become effective after the market […]
HONG KONG, Dec 17, 2021 – (ACN Newswire via SEAPRWire.com) – 2021 the 11th Hong Kong International Finance Forum & China Securities Golden Bauhinia Awards Ceremony, themed “The 14th Five-Year, a New Journey”, was held at Hong Kong Convention and Exhibition Center dated December 17, 2021. Around 200 financial officials […]
TOKYO, Nov 8, 2021 – (JCN Newswire via SEAPRWire.com) – Several leading Japanese technology firms, including BIRD INITIATIVE, Inc. (hereinafter “BIRD INITIATIVE”)(1), ANA HOLDINGS INC. (hereinafter “ANAHD”)(2), AIN HOLDINGS INC. (hereinafter “AIN HD”)(3), and NEC Corporation (hereinafter “NEC”),(4) have partnered with the Hokkaido Bureau of Economy, Trade and Industry (hereinafter […]
HONG KONG, Mar 31, 2021 – (ACN Newswire via SEAPRWire.com) – Viva Biotech Holdings (1873.HK) announced that during the year ended December 31, 2020 (the “Reporting Period”), revenue of the Group increased significantly to RMB 697.0 million from RMB 323.1 million for the corresponding period last year, representing a YoY […]